| Literature DB >> 30030527 |
Fernando Dos Santos1, Ivana C Moraes-Silva2, Edson D Moreira2, Maria-Claudia Irigoyen2.
Abstract
It is well-established that baroreflex sensitivity is essential for blood pressure control, and also plays a key role in the modulation of disease-induced metabolic alterations. In order to investigate the role of the baroreflex in the cardiometabolic and inflammatory derangements promoted by fructose overload, Wistar rats underwent sinoaortic denervation (SAD) or sham surgery and were studied 90 days after receiving tap water (Den and Ctrl) or a 10% fructose solution (Fruc and Den-Fruc). All experimental groups showed marked and similar degree of baroreflex impairment compared to Ctrl. As expected, fructose overload effectively induced metabolic syndrome; however, when it was associated with SAD, several alterations were attenuated. While Fruc rats displayed increased sympathetic modulation and tone and reduced vagal modulation compared to Ctrl animals, Den-Fruc rats showed greater vagal tone and modulation when compared to the Fruc group. Moreover, the Den-Fruc group showed augmented expression of β1 adrenergic receptors and TNF/IL-10 ratio and reduction of β2 in the left ventricle. The increase in vagal function was correlated with improved insulin sensitivity (r2 = 0.76), and decreased abdominal fat (r2 = -0.78) and β2 receptors (r2 = -0.85). Our results showed that: (1) chronic fructose overload induced severe baroreflex impairment, i.e. in a similar magnitude to that observed in SAD rats, which is accompanied by cardiometabolic dysfunctions; (2) the compensatory enhancement in parasympathetic function in SAD rats submitted to fructose intake may point out the possibility of use of approaches that improve vagal function as therapeutic target to attenuate fructose-induced cardiometabolic dysfunctions.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30030527 PMCID: PMC6054615 DOI: 10.1038/s41598-018-29336-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Baroreflex measurements.
| Ctrl | Fruc | Den | Den-Fruc | p | |
|---|---|---|---|---|---|
| Alpha LF (ms/mmHg) | 0.96 ± 0.06 | 0.70 ± 0.05* | 0.62 ± 0.09* | 0.61 ± 0.05* | 0.0009 |
| Total ramps | 812.50 ± 122.87 | 329.60 ± 43.54* | 360.50 ± 54.49* | 411.50 ± 47.45* | 0.0002 |
| BR ramps | 263.90 ± 45.03 | 33.20 ± 6.90* | 27.75 ± 5.63* | 27.38 ± 4.36* | 0.0001 |
| BEI | 0.32 ± 0.02 | 0.10 ± 0.01* | 0.08 ± 0.01* | 0.07 ± 0.01* | 0.0001 |
| Gain-up | 3.83 ± 0.29 | 1.73 ± 0.16* | 1.82 ± 0.41* | 1.89 ± 0.15* | 0.0001 |
| Gain-down | 2.74 ± 0.19 | 1.50 ± 0.11* | 1.44 ± 0.17* | 1.52 ± 0.20* | 0.0001 |
| Gain-total | 3.40 ± 0.23 | 1.68 ± 0.14* | 1.60 ± 0.22* | 1.74 ± 0.16* | 0.0001 |
Baroreflex activity and sensitivity measured by alpha index and sequence method. Control (Ctrl), Fructose overload (Fruc), sinoaortic denervation (Den), and Den associated with fructose overload (Den-Fruc). *p < 0.05 when compared to Ctrl by Bonferroni post-hot. ANOVA represented by p on graphic.
Weight and metabolic profile.
| Ctrl | Fruc | Den | Den-Fruc | p | |
|---|---|---|---|---|---|
| Body weight (g) | 506.32 ± 2.33 | 569.05 ± 5.25* | 459.20 ± 4.40*# | 550.80 ± 7.80*$ | 0.0001 |
| Abdominal fat (g) | 6.28 ± 0.63 | 12.42 ± 0.81* | 5.33 ± 0.52 | 8.21 ± 0.63#$ | 0.0001 |
| Glycemia (mg/dl) | 80.80 ± 4.15 | 93.20 ± 3.49 | 86.60 ± 2.66 | 89.40 ± 2.75 | 0.0909 |
| Total cholesterol (mg/dl) | 131.25 ± 8.31 | 240.36 ± 10.20* | 128.34 ± 7.65 | 153.36 ± 12.54# | 0.0001 |
| Triglycerides (mg/dl) | 112.36 ± 4.25 | 168.25 ± 6.63* | 123.65 ± 8.32 | 142.23 ± 7.35* | 0.0001 |
| kITT (%/min) | 3.48 ± 0.13 | 2.32 ± 0.11* | 3.78 ± 0.17 | 3.38 ± 0.11# | 0.0001 |
Measurements of body weight, abdominal fat, fasting glycaemia, total cholesterol, triglycerides, and constant of insulin tolerance test (kITT) at the end of the 90-day follow up. Control (Ctrl), Fructose overload (Fruc), sinoaortic denervation (Den), and Den associated with fructose overload (Den-Fruc). *p < 0.05 vs. Ctrl; #p < 0.05 vs. Fruc; $p < 0.05 vs. Den by Bonferroni post-hot. ANOVA represented by p on graphic.
Figure 1Autonomic blockade. Intrinsic heart rate (1A), sympathetic (1B) and vagal tone (1C) obtained by autonomic blockade with propranolol and methylatropine, respectively. Control (Ctrl), Fructose overload (Fruc), sinoaortic denervation (Den), and Den associated with fructose overload (Den-Fruc). *p < 0.05 vs. Ctrl; #p < 0.05 vs. Fruc by Bonferroni post-hoc, ANOVA (1A p = 0.240; 1B p = 0.006; 1C p = 0.018).
Hemodynamics, heart rate variability and systolic blood pressure variability.
| Ctrl | Fruc | Den | Den-Fruc | p | |
|---|---|---|---|---|---|
| HR (bpm) | 353.84 ± 4.69 | 351.53 ± 4.08 | 367.40 ± 7.94 | 399.07 ± 9.78*#$ | 0.0001 |
| VAR PI (ms2) | 135.13 ± 16.39 | 100.04 ± 10.13 | 45.65 ± 8.92* | 73.25 ± 17.20* | 0.0005 |
| LF PI (ms2) | 6.25 ± 0.98 | 14.99 ± 0.93* | 2.03 ± 0.46* | 2.85 ± 0.52*# | 0.0001 |
| HF PI (ms2) | 13.83 ± 0.95 | 12.57 ± 1.80 | 7.14 ± 0.64* | 8.33 ± 0.95* | 0.0013 |
| LF PI (%) | 11.40 ± 0.82 | 27.63 ± 0.83* | 9.63 ± 1.19 | 10.75 ± 0.67# | 0.0001 |
| HF PI (%) | 28.80 ± 2.18 | 22.04 ± 1.74 | 43.13 ± 5.03* | 39.13 ± 4.39# | 0.0003 |
| LF PI (nu) | 29.60 ± 2.46 | 56.15 ± 2.07* | 21.00 ± 3.69* | 23.63 ± 2.69# | 0.0001 |
| HF PI (nu) | 70.40 ± 2.46 | 43.85 ± 2.07* | 79.00 ± 3.69* | 76.38 ± 2.69# | 0.0001 |
| LF/HF | 0.48 ± 0.07 | 1.33 ± 0.11* | 0.31 ± 0.07* | 0.34 ± 0.05# | 0.0001 |
| SBP (mmHg) | 120.80 ± 1.07 | 143.05 ± 3.21* | 122.11 ± 5.09 | 136.68 ± 3.66*$ | 0.0001 |
| VAR SBP (mmHg2) | 42.10 ± 3.16 | 40.30 ± 2.43 | 106.22 ± 24.71* | 180.75 ± 40.34*# | 0.0001 |
| LF SBP (mmHg2) | 6.54 ± 0.57 | 9.37 ± 1.06* | 5.23 ± 0.75 | 7.77 ± 1.30 | 0.0260 |
Time and frequency domain of heart rate and blood pressure variability. Heart rate (HR), variance of pulse interval (VAR PI), square root of differences between consecutives PI intervals (RMSSD), low frequency band of pulse interval (LF PI), including absolute, percent and normalized units, high frequency of pulse interval (HF PI) including absolute, percent and normalized units, sympathovagal balance (LF/HF), systolic blood pressure (SBP), variance of SBP (VAR SBP) and low frequency band of SBP (LF SBP). Control (Ctrl), Fructose overload (Fruc), sinoaortic denervation (Den), and Den associated with fructose overload (Den-Fruc). *p < 0.05 vs. Ctrl; #p < 0.05 vs. Fruc; $p < 0.05 vs. Den by Bonferroni post-hot. ANOVA represented by p on graphic.
Figure 2β Receptors expression. Quantification of β1 (2A) and β2 (2B) receptors in the left ventricle (LV). Percentage of change compared to control group. Control (Ctrl), Fructose overload (Fruc), sinoaortic denervation (Den), and Den associated with fructose overload (Den-Fruc). *p < 0.05 vs. Ctrl; #p < 0.05 vs. Fruc; $p < 0.05 vs. Den by Bonferroni post-hoc, ANOVA (2A p < 0.001; 2B p < 0.001).
Figure 3Cardiac immunohistochemistry. Nuclear factor kappa B (NFκB) (3A) and interleukin-6 (IL-6) (3B) by immunohistochemistry in cardiac tissue. Control (Ctrl), Fructose overload (Fruc), sinoaortic denervation (Den), and Den associated with fructose overload (Den-Fruc). *p < 0.05 vs. Ctrl; #p < 0.05 vs. Fruc by Bonferroni post-hoc, ANOVA (3A p = 0.005; 3B p < 0.001).
Figure 4Cardiac inflammation. Tumor necrosis factor alpha (TNFα) (4A) interleukin-10 (IL-10) (4B) and the TNFα/IL-10 ratio (4C) by ELISA in cardiac tissue. Control (Ctrl), Fructose overload (Fruc), sinoaortic denervation (Den), and Den associated with fructose overload (Den-Fruc). *p < 0.05 vs. Ctrl; #p < 0.05 vs. Fruc by Bonferroni post-hoc, ANOVA (4A p = 0.018; 4B p = 0.039; 4C p = 0.023).
Association studies.
| All | Ctrl | Fruc | Den | Den-Fruc | |
|---|---|---|---|---|---|
| Sympathetic Tone and β2 | 0.3375 | 0.6574 | 0.6871 | 0.9246 | −0.9650 |
| Vagal Tone and β2 | −0.6325 | −0.6190 | −0.4857 | −0.9434 | −0.8569 |
| kITT and HF PI (%) | 0.7572 | 0.8128 | 0.1158 | 0.9454 | 0.2780 |
| KiTT and LF/HF | −0.7829 | −0.1536 | −0.4928 | −0.1257 | 0.1356 |
| HF PI % and Abdominal Fat | −0.7766 | 0.2897 | −0.0193 | 0.1361 | −0.2943 |
Correlation analysis (r2) between the following parameters: cardiac sympathetic tone and cardiac β2 receptors expression, cardiac vagal tone and cardiac β2 receptors expression, insulin sensitivity (kITT) and percentage of cardiac vagal modulation (HF), insulin sensitivity (kITT) and cardiac sympathovagal balance (LF/HF), and percentage of cardiac vagal modulation (HF) and abdominal fat. All groups together (All), Control (Ctrl), Fructose overload (Fruc), sinoaortic denervation (Den), and Den associated with fructose overload (Den-Fruc).